Carbetocin市场:目前分析与预测(2022-2030年)

由于产品频繁推出，预计Carbetocin市场在预测期内将以 5% 的复合年增长率强劲增长。例如，2021年9月，雅培实验室推出了Carbetocin单剂量製剂，用于预防产后出血。

为了更好地了解行业市场采用情况，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、意大利、西班牙、欧洲其他地区）、亚太地区（中国） 、日本、印度）、韩国、澳大利亚和亚太地区其他地区），以及基于其全球影响力的其他地区。2021年，北美将主导Carbetocin市场。这是由于美国等主要经济体的存在，以及高医疗保健支出是该地区Carbetocin市场增长的主要原因。例如，根据加拿大健康信息研究所的数据，2022年加拿大的医疗保健总支出约为3310亿美元，占加拿大人均支出8563美元。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 全球Carbetocin市场上新型冠状病毒感染疾病(COVID-19)的影响

第6章 全球Carbetocin市场收益，2020-2030年

第7章 市场洞察:各类型

• 首发医药品
• 学名药

第8章 市场洞察:各终端用户

• 医院
• 诊所
• 其他

第9章 市场洞察:各地区

• 北美的Carbetocin市场
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲的Carbetocin市场
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区的Carbetocin市场
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • APAC的其他各国
• 其他地区的Carbetocin市场

第10章 Carbetocin市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 Carbetocin市场机会

第12章 Carbetocin市场趋势

第13章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 企业简介

• Ferring B.V.
• Hybio Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Beacon Pharmaceuticals Limited
• SGPharma Pvt. Ltd.
• Taj Pharmaceuticals
• Abbott
• MANUS AKTTEVA BIOPHARMA LLP
• Enomark
• Sun Pharmaceutical Industries Ltd

第19章 免责声明

Carbetocin is a synthetic hormone used to prevent postpartum hemorrhage (PPH) in women who have just given birth. It works by stimulating contractions in the uterus to prevent excessive bleeding. Carbetocin is administered as an injection and is typically given after vaginal delivery or after a cesarean section. The market for carbetocin is expected to witness growth due to the increasing number of pregnancies and high fertility rate globally. For instance, as per the World Bank, in 2020, the global fertility rate of births per woman accounted for 2.3 and is expected to reach 2.1 by year 2050.

Carbetocin Market is expected to grow at a strong CAGR of 5% during the forecast period owing to the frequent product launches. For instance, In September 2021, Abbott Laboratory launched a single-dose formulation of carbetocin to prevent post partem hemorrhage.

Based on type, the market is segmented into original drug and generic drug. As per our analysis, the diagnosis segment acquired a major share in 2021. Duratocin is the original and the most widely used brand of carbetocin, and it is available in many countries around the world. This is mainly due to the high popularity of the brand and the quality of the brand offered by the companies attributes to the large share of the segment.

Based on the end-user, the market is segmented into hospitals, clinics, and others. The clinics segment is expected to grow with a higher CAGR in the carbetocin market during the forecast period. The maternity clinics have specialized professionals for gynae treatments is the main reason for the fast growth of the segment in the carbetocin market.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region held the dominant share of the carbetocin market in 2021. This is mainly due to the presence of major economies such as the U.S., along with the high healthcare spending is the main reason for the market growth of the region in the carbetocin market. For example, as per the Canadian Institute for Health Information, total health spending in Canada was around USD 331 billion in 2022 and per capita expenditure in Canada accounted for USD 8563.

Some of the major players operating in the market include: Ferring B.V.; Hybio Pharmaceutical Co., Ltd.; Pfizer Inc.; Beacon Pharmaceuticals Limited; SGPharma Pvt. Ltd.; Taj Pharmaceuticals; Abbott; MANUS AKTTEVA BIOPHARMA LLP; Enomark; and Sun Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Carbetocin Market
• 2.2. Research Methodology of the Carbetocin Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL CARBETOCIN MARKET COVID-19 IMPACT

6 GLOBAL CARBETOCIN MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

• 7.1. Original Drug
• 7.2. Generic Drug

8 MARKET INSIGHTS BY END-USER

• 8.1. Hospitals
• 8.2. Clinics
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America Carbetocin Market
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe Carbetocin Market
  • 9.2.1. Germany
  • 9.2.2. UK
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific Carbetocin Market
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Australia
  • 9.3.5. South Korea
  • 9.3.6. Rest of APAC
• 9.4. Rest of the World Carbetocin Market

10 CARBETOCIN MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 CARBETOCIN MARKET OPPORTUNITIES

12 CARBETOCIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. Ferring B.V.
• 18.2. Hybio Pharmaceutical Co., Ltd.
• 18.3. Pfizer Inc.
• 18.4. Beacon Pharmaceuticals Limited
• 18.5. SGPharma Pvt. Ltd.
• 18.6. Taj Pharmaceuticals
• 18.7. Abbott
• 18.8. MANUS AKTTEVA BIOPHARMA LLP
• 18.9. Enomark
• 18.10. Sun Pharmaceutical Industries Ltd

19 DISCLAIMER